The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Czibere Akos since 2026.
This trader's CIK number is 2049427.
At the time of last reporting, Czibere Akos was the Chief Medical Officer of Aktis Oncology, Inc.. (stock ticker symbol AKTS).
Also see all insider trading activities at Aktis Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | AKTS | 0 | $0 | 50,000 | $1,396,450 | 50,000 | $247,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-07-08 | AKTS | Sale | 50,000 | 27.93 | 1,396,450 |
| 2026-07-08 | AKTS | Option Ex | 50,000 | 4.95 | 247,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Czibere Akos (Chief Medical Officer of Aktis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.